Anticorps bispecifiques diriges contre cd3epsilon et bcma a utiliser dans le traitement de maladies

Bispecific antibodies against cd3epsilon and bcma for use in treatment of diseases

Abstract

The disclosure relates to bispecific antibodies against CD3c and BCMA for use in the treatment of diseases. The disclosure provides methods of determining the responsiveness of a patient to such treatment and relates to diagnostic assays.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)

    Title

Cited By (0)

    Publication numberPublication dateAssigneeTitle